|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 39/00 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| C07D 215/38 | (2006.01) | ||
| A61P 39/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| C07D 215/38 | (2013.01) |
| (11) | Patento numeris | 3337486 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16839942.6 |
| Europos patento paraiškos padavimo data | 2016-08-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/048054 |
| Data | 2016-08-22 |
| (87) | Numeris | WO 2017/035077 |
| Data | 2017-03-02 |
| (30) | Numeris | Data | Šalis |
| 201562208223 P | 2015-08-21 | US |
| (72) |
BRADY, Todd , US
YOUNG, Scott , US
KINNEY, William, A. , US
MACDONALD, Susan , US
|
| (73) |
Aldeyra Therapeutics, Inc. ,
131 Hartwell Avenue
Suite 320, Lexington, MA 02421,
US
|
| (54) | DEUTERATED COMPOUNDS AND USES THEREOF |
| DEUTERATED COMPOUNDS AND USES THEREOF |